After stopping unfractionated heparin (or low‑molecular‑weight heparin), how long should one wait before drawing a blood sample for a coagulation profile?

Timing of Blood Sample Collection for Coagulation Profile After Stopping Heparin

Blood samples for coagulation testing should be collected at least 4 hours after stopping unfractionated heparin (UFH) infusion and at least 12 hours after the last dose of low-molecular-weight heparin (LMWH). 1

Specific Timing Recommendations

For Unfractionated Heparin (UFH)

• Wait at least 4 hours after cessation of IV UFH infusion before drawing blood for coagulation studies 1
• This timing prevents heparin contamination of the sample, which can interfere with assay performance and lead to inaccurate results 1

For Low-Molecular-Weight Heparin (LMWH)

• Wait at least 12 hours after the last subcutaneous dose of LMWH before collecting blood samples 1
• The longer interval is necessary due to LMWH's extended half-life and subcutaneous absorption kinetics 1

Context for Specific Testing Scenarios

For Prothrombin Time (PT/INR) Testing

When heparin is given concurrently with warfarin and you need a valid prothrombin time:

• Wait at least 5 hours after the last IV UFH dose 2
• Wait 24 hours after the last subcutaneous heparin dose 2
• These intervals allow heparin's effect on PT testing to dissipate, providing accurate warfarin monitoring 2

Clinical Rationale

Heparin contamination of blood samples is a critical pitfall that can falsely prolong coagulation tests and lead to inappropriate clinical decisions 1. The recommended waiting periods ensure:

• Clearance of circulating heparin that would interfere with laboratory assays 1
• Accurate baseline coagulation parameters for clinical decision-making 1
• Reliable detection of underlying coagulation abnormalities without heparin artifact 1

Important Caveats

If urgent coagulation testing is needed before these time intervals, clinicians should:

• Clearly communicate to the laboratory that the patient recently received heparin 1
• Consider measuring heparin levels (anti-Xa activity) to confirm clearance, with levels <0.2 IU/mL considered acceptable 1
• Interpret results cautiously, recognizing potential heparin interference 1

For patients with suspected heparin-induced thrombocytopenia (HIT), these timing recommendations are particularly important to avoid false-positive functional assay results due to residual heparin in the sample 1.